Fehmı Tabak

8.2k citations
215 papers · 4.5k indexed · 1 hit paper · h-index 31

Impact in

  • Hepatology top 0.5%
    • Hepatitis C virus research
    • Hepatitis Viruses Studies and Epidemiology
    • Hepatitis B Virus Studies
    • Liver Disease Diagnosis and Treatment

Papers in

    • Hepatitis C virus research 81
    • Hepatitis Viruses Studies and Epidemiology 17
    • Hepatitis B Virus Studies 75
    • Liver Disease Diagnosis and Treatment 53
    • HIV, Drug Use, Sexual Risk 13

Fehmı Tabak

195 papers receiving 4.3k citations

Hit Papers

Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment 2020 · 611 citations
6112020202620222024200400600

Peers

Fehmı Tabak
Comparison fields: 5 of 129
  • Hepatology 1.7k
  • Epidemiology 2.5k
  • Infectious Diseases 1.2k
  • Molecular Medicine 224
  • Applied Microbiology and Biotechnology 84
Replace Reşat Özaras with:
Reşat Özaras Türkiye
Carlos Lumbreras Spain
José María Aguado Spain
Hsin‐Yun Sun Taiwan
Raymund R. Razonable United States
Ercole Concia Italy
Spinello Antinori Italy
Hee Jin Cheong South Korea
Carmen Quereda Spain
Mario Fernández‐Ruiz Spain
Fehmı Tabak relative to Reşat Özaras Türkiye Reşat Özaras's profile →
Citations per field
00.5×3.0×
Reşat Özaras · 1×
Citations per year

Countries citing papers authored by Fehmı Tabak

Since Specialization
Citations

This map shows the geographic impact of Fehmı Tabak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fehmı Tabak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fehmı Tabak more than expected).

Fields of papers citing papers by Fehmı Tabak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fehmı Tabak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fehmı Tabak. The network helps show where Fehmı Tabak may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Fehmı Tabak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fehmı Tabak Line = papers co-authored together Fehmı Tabak links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20241
4 20240
5 20232
6 20231
7 20233
8 20230
9 20224
10 202163
11 202127
12 20219
13 202118
14 202186
15 202037
16 201814
17
Rastlantısal Olarak HBsAg Pozitifliği Saptanan Hastalarda Karaciğer Hastalığının İrdelenmesi
20120
18 2008300
19
Investigations Survey on Prevalence of Cardiac Disease and its Risk Factors in Adults in Turkey: 4. Blood lipid Levels
19911
20
Survey on Prevalence of Cardiac Disease and its Risk Factors in Adults in Turkey: 3. Prevalence of Heart Diseases
19910

About Fehmı Tabak

Fehmı Tabak is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Microbiology and Emergency Medicine, having authored 215 papers that have together received 4.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (81 papers), Hepatitis B Virus Studies (75 papers), Liver Disease Diagnosis and Treatment (53 papers), Hepatitis Viruses Studies and Epidemiology (17 papers), HIV/AIDS Research and Interventions (16 papers), COVID-19 Clinical Research Studies (15 papers), Infectious Diseases and Tuberculosis (14 papers) and HIV, Drug Use, Sexual Risk (13 papers). The work is most often cited by research in Hepatology (1.7k citations), Epidemiology (2.5k citations), Infectious Diseases (1.2k citations), Molecular Medicine (224 citations) and Applied Microbiology and Biotechnology (84 citations). Fehmı Tabak has collaborated with scholars based in Türkiye, United States and Netherlands. Frequent co-authors include Reşat Özaras, Ali Mert, Mehmet Soy, Pamir Atagündüz, Servet Kayhan, Gökhan Keser, Işık Atagündüz, Recep Öztürk, Bilgül Mete and Bettina E. Hansen. Their work appears in journals such as Journal of Hepatology, Journal of Viral Hepatitis, Digestive Diseases and Sciences, International Journal of STD & AIDS and Diagnostic Microbiology and Infectious Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026